Offer - Urjas Oil for just ₹ 1
Symbiva 400 Capsule is a prescription drug, available for use as Capsule. It is typically used for the treatment of Asthma. Other than this, Symbiva 400 Capsule has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Symbiva 400 Capsule. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Common side effects of Symbiva 400 Capsule include Nasopharyngitis, Headache, Back Pain. Besides the aforementioned side effects, there are other adverse effects of Symbiva 400 Capsule as well, which are listed below. Such side effects of Symbiva 400 Capsule normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Symbiva 400 Capsule is Moderate for pregnant women and Moderate for women who are breastfeeding. In addition, Symbiva 400 Capsule's effects on the liver, heart and kidney are discussed below in the Symbiva 400 Capsule related warnings section.
Some other conditions that can be affected by Symbiva 400 Capsule are listed in the contraindications section below.
Additionally, Symbiva 400 Capsule may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Symbiva 400 Capsule is safe while driving, and is is addictive in nature.
Symbiva 400 Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Symbiva 400 Capsule safe for pregnant women?
Pregnant women may experience moderate side effects from Symbiva. It is best to stop taking Symbiva immediately and inform your doctor if you notice any discomfort.
Is the use of Symbiva 400 Capsule safe during breastfeeding?
Symbiva can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Symbiva 400 Capsule on the Kidneys?
There are no side effects of Symbiva on the kidneys.
What is the effect of Symbiva 400 Capsule on the Liver?
Symbiva does not damage the liver.
What is the effect of Symbiva 400 Capsule on the Heart?
Symbiva is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Symbiva 400 Capsule unless your doctor advises you to do so -
Is this Symbiva 400 Capsule habit forming or addictive?
No, you will not get addicted to Symbiva 400 Capsule.
Is it safe to drive or operate heavy machinery when consuming?
Symbiva 400 Capsule will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Symbiva 400 Capsule should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Symbiva 400 Capsule in mental disorders is not effective.
Interaction between Food and Symbiva 400 Capsule
Taking Symbiva 400 Capsule with food is safe.
Interaction between Alcohol and Symbiva 400 Capsule
Taking Symbiva 400 Capsule with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
Product Description [Internet]: SYMBICORT. AstraZeneca
